Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Ares Life Sciences

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$27M
Portfolio companies 2
Rounds per year 0.15
Lead investments 2
Exits 1
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Medical
  • Medical Device
  • Biotechnology
  • Pharmaceutical
Summary

In 2008 was created Ares Life Sciences, which is appeared as VC. The main department of described VC is located in the Geneva. The venture was found in Europe in Switzerland.

The top amount of exits for fund were in 2006. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2008.

The usual cause for the fund is to invest in rounds with 5 partakers. Despite the Ares Life Sciences, startups are often financed by NGN Capital, Menlo Ventures, HBM Healthcare Investments AG. The meaningful sponsors for the fund in investment in the same round are SightLine Partners, Saints Capital, Pac-Link. In the next rounds fund is usually obtained by YA Global Master SPV, Qiming Venture Partners, Intuitive Surgical.

Among the most popular portfolio startups of the fund, we may highlight Broncus Technologies, Santhera Pharmaceuticals. We can highlight the next thriving fund investment areas, such as Health Care, Pharmaceutical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

Read more

Funds with similar focus

Funds from Switzerland
Funds with similar focus located in Switzerland:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ares Life Sciences?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 27M
Rounds per year 0.15
Peak activity year 2008
Lead investments 2
Exits 1
Group Appearance index 0.50
Crunchbase icon

Content report

The following text will be sent to our editors: